samples were collected from, but does not currently address sample processing. The Biospecimen Reporting for Improved Study Quality (BRISQ) guidelines 9 suggest data to share about samples and their processing, but from our review of publications and biorepository websites, we infer that samples rarely have BRISQ data attached when they are sent to researchers. None of these efforts enable scientists to find and evaluate the best samples for their experiments. Most important, there is no current system that links clinical samples to the SOPs used to prepare them.
Biospecimen Commons was developed using the MIABIS guidelines for both biorepository and collection listings, and SOPs support the attachment of BRISQ codes. Biospecimen Commons already has 300 biorepositories listed and 154 sample-preparation SOPs published.
Biorepositories must adopt the use of SOPs (for those that do not practice this), and they should share their SOPs and link them to the appropriate sample sets. One way to encourage transparency might be to reward those biorepositories that do share SOPs with badges on their page entries and associated published articles. Journals could also encourage, or perhaps require, the use of links to protocol databases with accession numbers, similar to genomic and proteomic submissions. Funding agencies should insist that protocols used to collect samples using award money be made public. Researchers who obtain samples from biorepositories should request the SOPs used to prepare samples and cite the digital location of those SOPs in publications. By developing an environment of transparent processing of tissue samples, we can enable researchers to choose the best samples available for their experiments, leading to both more reproducible research and better allocation of these limited and valued resources. (Fig. 1a, Supplementary Fig. 1) . We demonstrate that with APT, ATAC-qPCR and allelic ATAC-PCR can accurately quantify differential and allele-specific chromatin accessibility at targeted loci for biomarker or functional studies, including the detection of functional somatic mutations in DNA regulatory elements in cancer cells.
Many fragments generated by Tn5 transposition during ATACseq are less than 100 base pairs long and thus are too short for quantification by qPCR. To overcome this limitation, APT identifies optimal regions for ATAC-qPCR primers within peaks by comparing the number of spanning fragments in overlapping windows to the normalized peak height across samples (Fig. 1b,  Supplementary Table 1) .
Differences in background signal and transcription start site enrichment between ATAC libraries can produce misleading ATAC-qPCR results if data are not normalized correctly. Normalization to elements with low variability between samples is analogous to sequencing-depth correction during standard ATAC-seq analysis. We identified universal normalization controls based on low-variance peaks across a panel of diverse human and mouse tissues from ATAC-seq data in ENCODE (Supplementary Fig. 2 ). APT can also identify custom normalization controls based on user-supplied ATAC-seq data. We tested the correlation between ATAC-qPCR and ATAC-seq, using a panel of differentially accessible elements in human fibroblasts after topoisomerase II inhibition, as well as a panel of random monoallelically accessible elements in mouse neural progenitor cells 2 
(Supplementary

ATAC Primer Tool for targeted analysis of accessible chromatin
To the Editor: ATAC-seq (assay for transposase-accessible chromatin with high-throughput sequencing) enables rapid, genomewide analysis of chromatin accessibility in a variety of cell types 1 . However, follow-up and hypothesis-driven analyses typically focus on only a small subset of these DNA elements. To facilitate high-throughput, low-cost analysis of chromatin accessibility, we developed ATAC Primer Tool (APT) for primer design and the identification of accurate normalization controls for ATAC-qPCR specific and universal normalization controls ( Supplementary  Fig. 3) .
A targeted allelic ATAC assay is highly desirable because only a small fraction of DNA elements (~1%) both possess informative sequence variants and demonstrate allelic regulation 2 . Inclusion of an informative SNP between primer-binding sites allows for targeted analysis of allele-specific accessibility by ATAC-PCR, for example, to assess the effect of disease-associated variants on allele-specific accessibility. For well-characterized TERT promoter mutations 3, 4 , ATAC-PCR and Sanger sequencing demonstrated that only the mutant allele conferred TERT promoter chromatin accessibility (Fig. 1c, Supplementary Table 4) . We further validated allelic ATAC-PCR on a panel of DNA elements with random monoallelic accessibility in hybrid mouse NPC cells 2 Table 5 ). Allele-specific quantification by ATAC-PCR correlated strongly with the allelic accessibility determined by ATAC-seq (R = 0.962) (Supplementary Fig. 4) , thus demonstrating accurate quantification of targeted and allelespecific accessibility by ATAC-PCR enabled by APT.
(Supplementary
Further information on experimental design is available in the Supplementary Methods and the Life Sciences Reporting Summary.
Software availability. The current APT software is available from GitHub (https://github.com/ChangLab/ATACPrimerTool) and as part of the Galaxy Tool Shed (details at https://github.com/ ChangLab/ATACPrimerTool/blob/master/Running_APT_with_ Galaxy.md).
Data availability. ATAC-seq data from human and mouse tissues were obtained from ENCODE; accession numbers are available in Supplementary Tables 6 and 7. ATAC-seq data from hybrid mouse neural progenitor cells are available at the Gene Expression Omnibus (GSE84646). 
Computational correction of index switching in multiplexed sequencing libraries
To the Editor: Contemporary sequencers allow for large-scale multiplexing of sequencing libraries. In the single-cell field, hundreds or thousands of libraries are typically sequenced in the same lane of an Illumina sequencer 1,2 . It is assumed that the integrity of each library depends on the experimental conditions before sequencing, but cross-library contamination can also occur during sequencing 3 . Newer Illumina sequencers that use exclusion amplification (e.g., HiSeq 3000, HiSeq 4000 and NovaSeq) seem especially vulnerable to index switching caused by free index primers, which generate 2-10% contaminated reads [4] [5] [6] . Libraries for which a single swapping event can lead to the erroneous assignment of sequence reads to cells (or samples) are most affected and include single-cell libraries multiplexed by combinatorial barcoding with i5 and i7 Nextera primers. We describe a strategy to estimate the fraction of affected counts and introduce a computational correction procedure for affected data. We observed that this correction removed most crosscontamination signal and that the corrected expression data no longer clustered by index or plate, leading to the rescue of previously sequenced libraries.
Although index switching occurs with low probability at both ends of sequences in a library, it rarely affects both ends of the same fragment 4 . Therefore, the read counts created by index switching (spread counts) retain information about their source. In each well, the spread counts can be considered as a linear combination of the true signals (source counts) spreading along the column and row of the library plate through index switching. We analyzed singlecell RNA-seq (scRNA-seq) data from mouse hematopoietic stem cells (HSCs) 4 generated in 384-well plates and sequenced on both the HiSeq 4000 (affected by index switching) and the NextSeq 500 (unaffected). Visualization of HiSeq read counts for specific genes in the 384-well library plate showed index switching from a single-cell source (Tacr1) and from multiple cells (Mki67) (Fig. 1) . By considering genes with significant (FDR < 0.05, hypergeometric test) index switching (Supplementary Methods), we estimated the fraction of contaminated reads via linear regression between the source counts and the aggregate of spread counts along the row and column (Fig.  1c) . The source counts explained the variance of spread counts to a high degree (R 2 = 0.9), and the regression suggested that 13% of the reads were contaminating in this HSC plate (Fig. 1c) . On average, each source read contributed 0.0098 spread counts per indexsharing well (rate of spreading) in this experiment (Fig. 1d) .
If an estimation of the spreading rate is available, the observed count matrix C for each gene can be expressed as the column spread (AX) plus the row spread (XB), where A and B model the column and row spread, respectively, and X is the count matrix unaffected by index switching. The resulting Sylvester equation is AX + XB = C and can be solved by existing algorithms (Supplementary Methods). We assigned each combination of primers an equal rate of spreading according to our estimation. We constructed matrices of the read 1 nature research | life sciences reporting summary Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes for ATAC-qPCR validation were chosen to represent the range of biological variation present in the samples, or included samples from all conditions.
Data exclusions
Describe any data exclusions. N/A
Replication
Describe whether the experimental findings were reliably reproduced.
All experiments were performed in technical duplicate. All conclusions were validated in multiple experimental systems.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
N/A
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
N/A
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section) For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All materials are available.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). 
